Clinical TrialsSearch results
Number of results: 2722
Other
- Phase I clinical trial of epitope peptides based vaccines both targeting RNF43 and VEGFR2 in patients with advanced colorectal cancer.
- unresectable colorectal cancer
- Institute of Medical Science The University of Tokyo
- 2007-12-23
Recruiting
- A phase II study by using CICS-1 and SPM-011 commissioned by CICS and STELLA PHARMA
- Unresectable angiosarcoma
- Hayashi Toshimitsu
- 2022-10-26
Not yet recruiting
- Correlation between prognosis and expressions of Mcl-1(Myeloid cell leukemia-1) and Stat-3(signal transducers and activator of transcription-3) in patients with metastasized or recurrent gastrointestinal malignancy
- Unresectable and recurrent gastric or colorectal carcinoma
- Keio University School of Medicine
- 2008-11-01
Other
- NCCH1907/MK008 trial
- unresectable alveolar soft tissue sarcoma
- Yonemori Kan
- 2020-06-01
Other
- Phase II study of Bevacizumab plus modified OPTIMOX1 in patients with unresectable advanced/recurrent colorectal cancer
- Unresectable advanced/recurrent colorectal cancer
- The Tokyo Cooperative Oncology Group
- 2008-06-01
Recruiting
- Phase II study of nab-paclitaxel plus ramucirumab in combination with nivolumab in unresectable advanced or recurrent gastric cancer after progression to first-line therapy including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody.
- Unresectable advanced or recurrent gastric cancer
- Shoji Hirokazu
- 2022-11-17
Other
- ONO-4538-113: A study to evaluate the efficacy and safety of ONO-4538 in combination with ipilimumab and chemotherapy in chemotherapy-naive participants with HER2-negative unresectable advanced or recurrent gastric cancer (including esophagogastric junction cancer)
- Unresectable advanced or recurrent gastric cancer
- Hirashima Yoshinori
- 2021-11-27
Recruiting
- Intestinal microbiota transplantation therapy combined with antibiotics for esophageal and gastric cancer patients using immune checkpoint inhibitors
- Unresectable advanced or recurrent esophageal cancer or gastric cancer
- Shoji Hirokazu
- 2024-06-18
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27
Other
- Phase II multicenter, double-blind, randomized controlled trial of FOLFOX therapy with bevacizumab in patients with unresectable advanced / recurrent small bowel cancer
- unresectable advanced / recurrent small bowel cancer
- Yamashita Haruhiro
- 2022-03-10